Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Apple Turns 50: From Garage Startup to AI Crossroads 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 
TEANECK, N.J., Jan. 05, 2017 -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review second quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, February 6, 2017.
Details for the webcast and conference call:
| Date: | Tuesday, February 7, 2017 | |||
| Time: | 9:00 AM Eastern Time | |||
| Location: | http://investors.pahc.com | |||
| U.S. Toll-Free: | +1 (877) 853-5634 | |||
| International Toll: | +1 (315) 625-6893 | |||
| Conference ID: | 20859240 | |||
NOTE: In order to join this conference call, all participants will be required to provide the Conference ID number.
Archive: A replay of the webcast and conference call will be available on Phibro’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $752 million for the fiscal year ended June 30, 2016. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact: Richard Johnson Phibro Animal Health Corporation Chief Financial Officer +1-201-329-7300 [email protected]
